Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.

[1]  J. Bosch,et al.  Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats. , 2013, Journal of hepatology.

[2]  J. Bosch,et al.  Interaction between NO and COX pathways modulating hepatic endothelial cells from control and cirrhotic rats , 2012, Journal of cellular and molecular medicine.

[3]  B. Lavina,et al.  PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats. , 2012, Journal of hepatology.

[4]  U. Förstermann,et al.  Cardiovascular effects and molecular targets of resveratrol. , 2012, Nitric oxide : biology and chemistry.

[5]  Han‐Chieh Lin,et al.  The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury. , 2011, Molecular nutrition & food research.

[6]  G. Omurtag,et al.  Resveratrol ameliorates oxidative DNA damage and protects against acrylamide-induced oxidative stress in rats , 2011, Molecular Biology Reports.

[7]  B. Lavina,et al.  Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats. , 2011, Journal of hepatology.

[8]  Mercedes Fernandez,et al.  Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. , 2010, Journal of hepatology.

[9]  A. S. Darvesh,et al.  Resveratrol and liver disease: from bench to bedside and community , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[10]  Sik Yoon,et al.  Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats , 2010, Archives of pharmacal research.

[11]  Liangyi Si,et al.  Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase. , 2009, Biochemical and biophysical research communications.

[12]  S. Gırgın,et al.  Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats. , 2008, World journal of gastroenterology.

[13]  J. García-Pagán,et al.  Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension , 2008, Gut.

[14]  R. Bataller,et al.  Large‐conductance calcium‐activated potassium channels modulate vascular tone in experimental cirrhosis , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[15]  J. Stuart,et al.  Molecular mechanisms of oxidative stress resistance induced by resveratrol: Specific and progressive induction of MnSOD. , 2008, Biochemical and biophysical research communications.

[16]  V. Pérez-Alvarez,et al.  Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat , 2008, Journal of applied toxicology : JAT.

[17]  S. Friedman,et al.  Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic Rats , 2008, Journal of Pharmacology and Experimental Therapeutics.

[18]  G. Tucker,et al.  Effects of dietary polyphenols on gene expression in human vascular endothelial cells , 2008, Proceedings of the Nutrition Society.

[19]  V. Tsutsumi,et al.  Resveratrol prevents fibrosis, NF‐κB activation and TGF‐β increases induced by chronic CCl4 treatment in rats , 2008 .

[20]  Mercedes Fernandez,et al.  Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability , 2007, Hepatology.

[21]  J. Bosch,et al.  Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers. , 2007, Journal of hepatology.

[22]  J. Bosch,et al.  Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats. , 2007, Journal of hepatology.

[23]  M. Hammami,et al.  Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. , 2007, Life sciences.

[24]  J. Bosch,et al.  Potential role of antioxidants in the treatment of portal hypertension. , 2007, Journal of hepatology.

[25]  Joseph A. Baur,et al.  Therapeutic potential of resveratrol: the in vivo evidence , 2006, Nature Reviews Drug Discovery.

[26]  H. Kırımlıoğlu,et al.  Protective effect of resveratrol against oxidative stress in cholestasis. , 2005, The Journal of surgical research.

[27]  J. Rodés,et al.  Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[28]  D. Brenner,et al.  Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282) , 2005 .

[29]  S. Friedman,et al.  Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis , 2004, Gut.

[30]  N. Seeram,et al.  Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. , 2004, Anticancer research.

[31]  L. Stivala,et al.  Resveratrol is a Peroxidase-mediated Inactivator of COX-1 but Not COX-2 , 2004, Journal of Biological Chemistry.

[32]  Xianglin Shi,et al.  Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. , 2003, Biochemical and biophysical research communications.

[33]  J. Rodés,et al.  Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers. , 2003, Journal of hepatology.

[34]  Z. Dong.  Molecular mechanism of the chemopreventive effect of resveratrol. , 2003, Mutation research.

[35]  J. Rodés,et al.  Cyclooxygenase‐derived products modulate the increased intrahepatic resistance of cirrhotic rat livers , 2003, Hepatology.

[36]  U. Förstermann,et al.  Resveratrol, a Polyphenolic Phytoalexin Present in Red Wine, Enhances Expression and Activity of Endothelial Nitric Oxide Synthase , 2002, Circulation.

[37]  J. Rodés,et al.  5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes. , 2002, Gastroenterology.

[38]  G. McCaughan,et al.  Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection , 2000, Gut.

[39]  L. Frémont.  Biological effects of resveratrol. , 2000, Life sciences.

[40]  T. Gupta,et al.  Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats , 1998, Hepatology.

[41]  D. Rockey,et al.  Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. , 1998, Gastroenterology.

[42]  L. Barrier,et al.  Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. , 1997, Life sciences.

[43]  E. Diamandis,et al.  The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. , 1995, Clinica chimica acta; international journal of clinical chemistry.